APLS icon

Apellis Pharmaceuticals
APLS

Overview Fund Activity

174 hedge funds and large institutions have $2.8B invested in Apellis Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 53 increasing their positions, 62 reducing their positions, and 21 closing their positions.

Holders
174
Holders Change
+6
Holders Change %
+3.57%
% of All Funds
3.06%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.09%
New
28
Increased
53
Reduced
62
Closed
21
Calls
$24.1M
Puts
$7.55M
Net Calls
+$16.5M
Net Calls Change
+$7.14M

Top Buyers

1
ACA
1
Avoro Capital Advisors
New York
$42.9M
2
BBA
2
Baker Bros. Advisors
New York
$71.8M
3
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$156M
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$262M
5
Fidelity Investments
5
Fidelity Investments
Massachusetts
$69.6M

Top Sellers

1
Citadel Advisors
1
Citadel Advisors
Florida
$2.26M
2
APM
2
Avidity Partners Management
Texas
$0
3
HA
3
HHLR Advisors
Cayman Islands
$196M
4
LGM
4
Logos Global Management
California
$0
5
State Street
5
State Street
Massachusetts
$94.3M
Name Market Value Shares Shares
Change 		Shares
Change %
JGC
201
J. Goldman & Co
New York
– – – –
5 6 7 8
9